Metallodrugs is devoted to the publication of high-quality research in all areas of medicinal inorganic chemistry ranging from the development of drugs for the treatment of a variety of diseases and conditions, such as metal-based anticancer agents, CO releasing compounds, insulin mimetics, antimicrobial and antiviral agents, to all kinds of diagnostic agents including contrast agents for imaging and radiopharmaceuticals. Submissions focusing on all aspects of metallodrug development will be considered. These include publications on synthesis, biological testing, mode of action determination, up to preclinical and clinical studies. The primary mission of the journal is to become the central publication venue for all members of the research community in Medicinal Inorganic Chemistry.
- Further information
- Category Links